OMT Capital Management’s Abiomed Inc ABMD Stock Holding History

OMT Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$601K	Buy	6,660 +1,420	+27%	+$121K	1.15%	26
2015 Q3	$486K	Sell	5,240 -9,260	-64%	-$816K	0.59%	33
2015 Q2	$953K	Sell	14,500 -4,150	-22%	-$276K	1%	31
2015 Q1	$1.33M	Sell	18,650 -107,350	-85%	-$5.83M	1.21%	30
2014 Q4	$4.8M	Sell	126,000 -188,360	-60%	-$5.94M	4.1%	10
2014 Q3	$7.81M	Sell	314,360 -102,150	-25%	-$2.59M	4.66%	7
2014 Q2	$10.5M	Sell	416,510 -98,440	-19%	-$2.29M	4.61%	7
2014 Q1	$13.4M	Sell	514,950 -117,400	-19%	-$3.25M	4.23%	8
2013 Q4	$16.9M	Buy	632,350 +19,200	+3%	+$474K	5.11%	2
2013 Q3	$11.7M	Buy	613,150 +26,190	+4%	+$599K	3.86%	10
2013 Q2	$12.7M	Buy	+586,960	New	+$11.8M	4.29%	7

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

OMT Capital Management's ABMD Position: Q4 2015 in Review

OMT Capital Management increased its Abiomed Inc (ABMD) stake by 27% in Q4 2015, buying an estimated $121K and bringing the position to 6,660 shares worth $601K. The position accounts for 1.15% of the portfolio, ranked #26.

OMT Capital Management first reported a position in ABMD in Q2 2013 and has held it in 11 quarters since. The position peaked at $16.9M in Q4 2013. 249 funds tracked by Wall St. Rank hold ABMD as of Q4 2015.

OMT Capital Management held 6,660 shares of Abiomed Inc worth $601K as of Q4 2015.
OMT Capital Management bought 1,420 Abiomed Inc shares in Q4 2015, an estimated $121K.
Abiomed Inc made up 1.15% of OMT Capital Management's portfolio in Q4 2015, its #26 holding.
OMT Capital Management first reported a position in Abiomed Inc in Q2 2013 and has held it in 11 quarters since.
OMT Capital Management's Abiomed Inc position peaked at $16.9M in Q4 2013.
249 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2015.

Based on OMT Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.